Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Radiol. Jul 28, 2013; 5(7): 259-263
Published online Jul 28, 2013. doi: 10.4329/wjr.v5.i7.259
Published online Jul 28, 2013. doi: 10.4329/wjr.v5.i7.259
Prostate magnetic resonance imaging at 3 Tesla: Is administration of hyoscine-N-butyl-bromide mandatory?
Matthias C Roethke, Alexander Radbruch, Heinz-Peter Schlemmer, Department of Radiology, German Cancer Research Center Heidelberg (DKFZ), 69120 Heidelberg, Germany
Timur H Kuru, Boris Hadaschik, Department of Urology, Universityhospital Heidelberg, 69120 Heidelberg, Germany
Author contributions: Roethke MC, Radbruch A and Kuru TH designed the study; Roethke MC, Kuru TH and Schlemmer HP were responsible for acquisition and evaluation of the scans; Roethke MC, Hadaschik B and Schlemmer HP critically revised the manuscript; Roethke MC and Schlemmer HP wrote the paper; all authors contributed to supportive work.
Correspondence to: Dr. Matthias C Roethke, MD, Department of Radiology, German Cancer Research Center Heidelberg (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. m.roethke@dkfz-heidelberg.de
Telephone: +49-6221-422520 Fax: +49-6221-422531
Received: April 3, 2013
Revised: May 23, 2013
Accepted: July 4, 2013
Published online: July 28, 2013
Revised: May 23, 2013
Accepted: July 4, 2013
Published online: July 28, 2013
Core Tip
Core tip: The study demonstrated no significant effect of hyoscine-N-butyl-bromide (HBB) (butylscopolamine) administration on image quality of prostate magnetic resonance imaging (MRI) at 3.0 Tesla without using an endorectal coil. The results suggest that the use of HBB is not generally mandatory for MRI of the prostate.